Breakthrough discovery in cancer therapy
Sartar Therapeutics was established to advance a breakthrough discovery in cancer therapy. Using gene expression profiling, we found exceptionally high phosphodiesterase 3A (PDE3A) gene expression in gastrointestinal stromal tumor (GIST), other soft tissue sarcoma subtypes and subsets of other cancers. Our discovery of a novel cancer target, PDE3A, represents a significant leap in cancer therapy.
Innovative precision treatment
We are developing SAR003, a first-in-class breakthrough targeted therapy for cancers expressing the PDE3A gene. Our first indication is gastrointestinal stromal tumour (GIST), a cancer where all tumors express the PDE3A gene.
We have strong IP, patent protection and Orphan Drug Designations (ODD) from EMA and FDA for the treatment of GIST using SAR003.
SAR003 functions as a molecular glue to induce cancer cell death in rapidly dividing cancer cells. Our preclinical proof-of-concept data from sophisticated in vivo models shows outstanding efficacy.
Read more
Sartar Team
Sartar is a company dedicated to the development of targeted therapies for hard-to-treat cancers. Our experienced team is supported by key leading clinical opinion leaders in Europe and US, and a world class vendor network.
Read moreNews
International Rare Disease Day
Today is the Rare Disease Day, a day dedicated to raising awareness about the many rare disease types that, while individually uncommon, collectively impact a significant number of patients worldwide. Among these are several rare cancers like soft tissue sarcomas including leiomyosarcoma, liposarcoma, and of course gastrointestinal stromal tumors (GIST), each presenting unique challenges in […]
Read articleWorld Cancer Day
The agenda of the World Cancer Day 4th of February 2025 is to share stories. Each cancer story is unique. Each patient is unique. We hope Sartar to be a part of these stories by lowering the burden and finding solutions for unmet medical needs.
Read articleSeason’s greetings from Sartar Therapeutics
Sartar Team wishes everyone a relaxing break and sparks of success for the upcoming year!
Read article